A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
Recruiting · NCT05669430 · Registry updated 2025-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cutaneous melanoma, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, refractory malignant neoplasm, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2025-02-13 | NCT05669430 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| GV20 Therapeutics | 4 |
| Merck Sharp & Dohme LLC | 650 |
13 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center | Detroit | United States | 3 |
| Community Health Network, Inc. | Indianapolis | United States | 3 |
| Florida Cancer Specialists & Research Institute, LLC | Fort Myers | United States | 2 |
| HealthONE Clinic Services Oncology - Hematology, LLC d/b/a Sarah Cannon Research Institute at HealthONE | Denver | United States | 1 |
| Massachusetts General Hospital | Boston | United States | 1015 |
| NYU Langone Health | New York | United States | 403 |
| Oncology Consultants, P.A. | Houston | United States | 9 |
| Oregon Health & Science University | Portland | United States | 261 |
| The Angeles Clinic and Research Institute | Los Angeles | United States | 16 |
| The University of Texas M. D. Anderson Cancer Center | Houston | United States | 88 |
| Verdi Oncology Tennessee, Scri Oncology Partners | Nashville | United States | 1 |
| Virginia Cancer Specialists | Fairfax | United States | 109 |
| Yale University | New Haven | United States | 44 |